Sign In
Buy LFCR
$4.42
+0.0600 (+1.38%)
At Close: Jul 31, 2026
Lifecore Biomedical Announces Chief Financial Officer Transition
07:00am, Thursday, 29'th Aug 2024
Experienced CDMO Industry Financial Executive Ryan Lake Appointed CFO Experienced CDMO Industry Financial Executive Ryan Lake Appointed CFO
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Lifecore Biomedical, Inc. ("Lifecore" or the "Company") (NASDAQ:LFCR) and certa
Investors Are Encouraged By The Schall Law Firm To Participate In A Lawsuit Against Lifecore Biomedical Inc For Securities Fraud
11:00am, Wednesday, 28'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lifecore Biomedical, Inc. ("Lif
NEW YORK CITY, NY / ACCESSWIRE / August 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lifecore
SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Lifecore Biomedical, Inc. (
LOS ANGELES, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 27, 2024 deadline to file a lead plaintiff motion in the class actio
Lifecore Biomedical, Inc. (LFCR) Q4 2024 Earnings Conference Call Transcript
01:56pm, Tuesday, 27'th Aug 2024
Lifecore Biomedical, Inc. (NASDAQ:LFCR ) Q4 2024 Earnings Conference Call August 27, 2024 8:30 AM ET Company Participants Stephanie Diaz - Vida Strategic Partners, IR Paul Josephs - President & CEO Jo
Lifecore Biomedical Inc Is Being Sued For Possible Securities Law Violations And The Schall Law Firm Invites Shareholders To Assist
11:00am, Tuesday, 27'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lifecore Biomedical, Inc. ("Lif
NEW YORK CITY, NY / ACCESSWIRE / August 27, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lifecore
NEW YORK, Aug. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lifecore Biomedical, Inc. (NASDAQ: LFCR) between October 7, 2020
Lifecore Biomedical Reports Fourth Quarter and Fiscal Year End 2024 Financial Results and Provides Corporate Update
05:23pm, Monday, 26'th Aug 2024
-- Recorded Revenues of $128.3 million for Fiscal 2024; Year-Over-Year Increase of 24.2% -- -- High Value Pipeline Continues to Advance Toward Commercialization -- -- State-of-the-Art Technology Enha
NEW YORK , Aug. 26, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Lifecore Biomedical, Inc. ("Lifecore" or the "Company") (NASDAQ: LFCR) and certain o
The Schall Law Firm Is Seeking Investor Participation In A Securities Fraud Case Against Lifecore Biomedical Inc.
11:00am, Monday, 26'th Aug 2024
LOS ANGELES, CA / ACCESSWIRE / August 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Lifecore Biomedical, Inc. ("Lif
NEW YORK CITY, NY / ACCESSWIRE / August 26, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Lifecore
NEW YORK--(BUSINESS WIRE)---- $LFCR--The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Minnesota on behalf
